Top Story

Combined-modality treatment effective for muscle-invasive bladder cancer

November 25, 2014

Patients with muscle-invasive bladder cancer who underwent bladder-preserving combined-modality therapy experienced disease-specific survival comparable to that typically observed with cystectomy, according to results of a pooled analysis.

Radical cystectomy remains standard treatment for muscle-invasive bladder cancer, yet bladder-preserving treatment strategies have improved due to evolution of radiation therapy, chemotherapy and patient selection, according to background information provided in the study.

In the JournalsPerspective

Gleason score associated with time to development of neuroendocrine prostate cancer

November 25, 2014
Gleason scores among patients with conventional prostatic adenocarcinoma was significantly associated with time to development of treatment-related neuroendocrine…
Meeting News Coverage

Biopsies more costly, less effective in lung cancer diagnosis

November 25, 2014
Biopsies were identified as the most costly tests in lung cancer diagnosis, with negative biopsies accounting for 43.1% of total diagnostic costs, according to study…
Meeting News Coverage

Family history influenced risk for triple-negative breast cancer in women of Mexican descent

November 24, 2014
Women of Mexican descent diagnosed with breast cancer were twice as likely to present with triple-negative disease than other subtypes if they had a family history of…
William Maisel, MD, MPH FDA News

FDA warns against laparoscopic power morcellation for hysterectomy, myomectomy

November 24, 2014
The FDA today released an “immediately in effect” guidance that recommends laparoscopic power morcellators list a boxed warning and two contraindications on…
More News Headlines »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan